Passage Bio, Inc. Common Stock (PASG) is a publicly traded Healthcare sector company. As of May 21, 2026, PASG trades at $5.00 with a market cap of $16.42M and a P/E ratio of -0.37. PASG moved +5.31% today. Year to date, PASG is -67.72%; over the trailing twelve months it is -17.25%. Its 52-week range spans $3.94 to $26.60. Analyst consensus is neutral with an average price target of $11.75. Rallies surfaces PASG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Passage Bio, Inc. Common Stock (PASG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PASG moved +5.31% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $5.00 |
| Market Cap | $16.42M |
| P/E Ratio | -0.37 |
| EPS | $-14.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.60 |
| 52-Week Low | $3.94 |
| Volume | 160 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.52M |
| Gross Margin | 0.00% |
5 analysts cover PASG: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.75.